ATE55130T1 - Verfahren zur herstellung von alpha-n((hypoxanthin-9-yl)-pentyloxycarbonyl>-arginin. - Google Patents
Verfahren zur herstellung von alpha-n((hypoxanthin-9-yl)-pentyloxycarbonyl>-arginin.Info
- Publication number
- ATE55130T1 ATE55130T1 AT87113168T AT87113168T ATE55130T1 AT E55130 T1 ATE55130 T1 AT E55130T1 AT 87113168 T AT87113168 T AT 87113168T AT 87113168 T AT87113168 T AT 87113168T AT E55130 T1 ATE55130 T1 AT E55130T1
- Authority
- AT
- Austria
- Prior art keywords
- pentyloxycarbonyl
- hypoxanthine
- arginine
- alpha
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8621734A IT1213495B (it) | 1986-09-17 | 1986-09-17 | Processo per la preparazione dell'alfa-n-[(ipoxatin-9-il)pentilossicarbonil-]arginina |
| EP87113168A EP0260588B1 (en) | 1986-09-17 | 1987-09-09 | Process for the preparation of alpha-N-[(hypoxanthin-9-yl)-pentyloxycarbonyl]-arginine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE55130T1 true ATE55130T1 (de) | 1990-08-15 |
Family
ID=11186113
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87113168T ATE55130T1 (de) | 1986-09-17 | 1987-09-09 | Verfahren zur herstellung von alpha-n((hypoxanthin-9-yl)-pentyloxycarbonyl>-arginin. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0260588B1 (es) |
| JP (1) | JPS6388184A (es) |
| KR (1) | KR950008971B1 (es) |
| AR (1) | AR242576A1 (es) |
| AT (1) | ATE55130T1 (es) |
| AU (1) | AU593136B2 (es) |
| CA (1) | CA1276148C (es) |
| DE (1) | DE3764051D1 (es) |
| DK (1) | DK168570B1 (es) |
| ES (1) | ES2017485B3 (es) |
| GR (1) | GR3000796T3 (es) |
| IL (1) | IL83863A0 (es) |
| IN (1) | IN165609B (es) |
| IT (1) | IT1213495B (es) |
| PH (1) | PH25318A (es) |
| ZA (1) | ZA876961B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1241452B (it) * | 1990-06-28 | 1994-01-17 | Sigma Tau Ind Farmaceuti | Derivati oligopeptidici dell'ipoxantina dotati di attivita' immunomodulante e composizioni farmaceutiche che li contengono |
| IT1244501B (it) * | 1991-03-22 | 1994-07-15 | Sigma Tau Ind Farmaceuti | Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono |
| US5994361A (en) * | 1994-06-22 | 1999-11-30 | Biochem Pharma | Substituted purinyl derivatives with immunomodulating activity |
| EP2332522A3 (en) | 1998-03-19 | 2011-12-07 | Bristol-Myers Squibb Company | Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| AU2011276254B2 (en) | 2010-07-09 | 2016-11-03 | James Trinca Green | Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4221910A (en) * | 1978-09-15 | 1980-09-09 | Newport Pharmaceuticals International, Inc. | 9-(Hydroxy alkyl)purines |
| AU564576B2 (en) * | 1981-09-24 | 1987-08-20 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Purine derivatives |
-
1986
- 1986-09-17 IT IT8621734A patent/IT1213495B/it active
-
1987
- 1987-09-09 AT AT87113168T patent/ATE55130T1/de not_active IP Right Cessation
- 1987-09-09 EP EP87113168A patent/EP0260588B1/en not_active Expired - Lifetime
- 1987-09-09 ES ES87113168T patent/ES2017485B3/es not_active Expired - Lifetime
- 1987-09-09 DE DE8787113168T patent/DE3764051D1/de not_active Expired - Fee Related
- 1987-09-10 PH PH35793A patent/PH25318A/en unknown
- 1987-09-10 IL IL83863A patent/IL83863A0/xx unknown
- 1987-09-11 JP JP62228206A patent/JPS6388184A/ja active Pending
- 1987-09-14 IN IN669/MAS/87A patent/IN165609B/en unknown
- 1987-09-16 ZA ZA876961A patent/ZA876961B/xx unknown
- 1987-09-16 AR AR87308744A patent/AR242576A1/es active
- 1987-09-16 KR KR1019870010239A patent/KR950008971B1/ko not_active IP Right Cessation
- 1987-09-16 CA CA000547042A patent/CA1276148C/en not_active Expired - Fee Related
- 1987-09-16 AU AU78471/87A patent/AU593136B2/en not_active Ceased
- 1987-09-17 DK DK489087A patent/DK168570B1/da not_active IP Right Cessation
-
1990
- 1990-09-14 GR GR90400651T patent/GR3000796T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR880003944A (ko) | 1988-06-01 |
| EP0260588B1 (en) | 1990-08-01 |
| DE3764051D1 (de) | 1990-09-06 |
| AU593136B2 (en) | 1990-02-01 |
| DK168570B1 (da) | 1994-04-25 |
| PH25318A (en) | 1991-04-30 |
| IN165609B (es) | 1989-11-25 |
| IL83863A0 (en) | 1988-02-29 |
| CA1276148C (en) | 1990-11-13 |
| DK489087A (da) | 1988-03-18 |
| ES2017485B3 (es) | 1991-02-16 |
| JPS6388184A (ja) | 1988-04-19 |
| KR950008971B1 (ko) | 1995-08-10 |
| ZA876961B (en) | 1988-05-25 |
| AU7847187A (en) | 1988-03-24 |
| GR3000796T3 (en) | 1991-10-10 |
| EP0260588A1 (en) | 1988-03-23 |
| AR242576A1 (es) | 1993-04-30 |
| DK489087D0 (da) | 1987-09-17 |
| IT1213495B (it) | 1989-12-20 |
| IT8621734A0 (it) | 1986-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3789746D1 (de) | Verfahren zur Herstellung von Zink-Nickel-Phosphatüberzügen. | |
| ATE66678T1 (de) | Verfahren zur herstellung von makrolidderivaten. | |
| DE3751018D1 (de) | Verfahren zur Herstellung von direkt-positiven Bildern. | |
| DE3787937T2 (de) | Verfahren zur Herstellung von metallisierten Bildern. | |
| DE68916130D1 (de) | Verfahren zur Herstellung von Block-copolyamid. | |
| DE58908451D1 (de) | Verfahren zur Herstellung von Organochlorsilanen. | |
| DE3750318D1 (de) | Verfahren zur Herstellung von Halosilanen. | |
| DE3789557D1 (de) | Verfahren zur Herstellung von Maleimid. | |
| DE3789680D1 (de) | Verfahren zur Herstellung von Halbleiterbauelementen. | |
| DE3772341D1 (de) | Verfahren zur herstellung von carbonsaeuren. | |
| DE3789412T2 (de) | Verfahren zur Herstellung von 3-Alkoxymethylcephalosporinen. | |
| ATE86619T1 (de) | Verfahren zur herstellung von nitroethenderivaten. | |
| DE3768148D1 (de) | Verfahren zur herstellung von carbonsaeuren. | |
| DE58906122D1 (de) | Verfahren zur Herstellung von Phenylethanolen. | |
| ATE55130T1 (de) | Verfahren zur herstellung von alpha-n((hypoxanthin-9-yl)-pentyloxycarbonyl>-arginin. | |
| DE3884070D1 (de) | Verfahren zur Herstellung von Harnstoffen. | |
| DE3862774D1 (de) | Verfahren zur herstellung von vinylphosphonsaeuredialkylestern. | |
| ATE85321T1 (de) | Verfahren zur herstellung von anilinofumaraten. | |
| DE3880902D1 (de) | Verfahren zur herstellung von hydroxybenzoesaeure. | |
| DE3886786T2 (de) | Verfahren zur Herstellung von Cimetidin. | |
| DE3761090D1 (de) | Verfahren zur herstellung von diethylenglykoldialkylethern. | |
| ATE74911T1 (de) | Verfahren zur herstellung von chinolincarbons|urederivaten. | |
| ATE80662T1 (de) | Verfahren zur herstellung von l-sorbose. | |
| ATE82243T1 (de) | Verfahren zur herstellung von propinol. | |
| ATE90327T1 (de) | Verfahren zur herstellung von phenylacetaldehyden. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |